Deadly Meningitis Outbreak Tied to More Drugs, FDA Says

A second steroid manufactured by New England Compounding Center has been linked to another potential meningitis infection, U.S. regulators said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.